These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 7663658)
21. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821 [TBL] [Abstract][Full Text] [Related]
22. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group. Harms HK; Matouk E; Tournier G; von der Hardt H; Weller PH; Romano L; Heijerman HG; FitzGerald MX; Richard D; Strandvik B; Kolbe J; Kraemer R; Michalsen H Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909 [TBL] [Abstract][Full Text] [Related]
23. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement]. Hodson M Arch Pediatr; 1995 Jul; 2(7):679-81. PubMed ID: 7663660 [TBL] [Abstract][Full Text] [Related]
24. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. Homnick DN; Marks JH; Rubin BK J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752 [TBL] [Abstract][Full Text] [Related]
26. Numerical and experimental investigation of mucociliary clearance breakdown in cystic fibrosis. Chatelin R; Anne-Archard D; Murris-Espin M; Thiriet M; Poncet P J Biomech; 2017 Feb; 53():56-63. PubMed ID: 28117099 [TBL] [Abstract][Full Text] [Related]
27. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease. Dasgupta B; Brown NE; King M Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074 [TBL] [Abstract][Full Text] [Related]
28. Effects of drugs on mucus clearance. Houtmeyers E; Gosselink R; Gayan-Ramirez G; Decramer M Eur Respir J; 1999 Aug; 14(2):452-67. PubMed ID: 10515429 [TBL] [Abstract][Full Text] [Related]
29. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis. Hodson ME Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698 [TBL] [Abstract][Full Text] [Related]
31. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients. Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742 [TBL] [Abstract][Full Text] [Related]
32. Mucus structure and properties in cystic fibrosis. Rubin BK Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972 [TBL] [Abstract][Full Text] [Related]
33. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815 [TBL] [Abstract][Full Text] [Related]
34. Effects of administration of aerosolized recombinant human deoxyribonuclease on resting energy expenditure in patients with cystic fibrosis. Amin N; Dozor AJ Pediatr Pulmonol; 1994 Sep; 18(3):150-4. PubMed ID: 7800431 [TBL] [Abstract][Full Text] [Related]
35. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease. Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409 [TBL] [Abstract][Full Text] [Related]
36. Clinical trials of recombinant human DNase in cystic fibrosis patients. Aitken ML Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306 [TBL] [Abstract][Full Text] [Related]
38. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial. Minasian C; Wallis C; Metcalfe C; Bush A Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349 [TBL] [Abstract][Full Text] [Related]
39. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. Shibuya Y; Wills PJ; Cole PJ Respirology; 2003 Jun; 8(2):181-5. PubMed ID: 12753533 [TBL] [Abstract][Full Text] [Related]